Peru In-Vitro Diagnostics Market is predicted to reach USD 163.3 Million by 2030

According to the study by Next Move Strategy Consulting, the Peru In-Vitro Diagnostics Market size is predicted to reach USD 163.3 million, at a CAGR of 2.4% by 2030.

Request a FREE Sample: https://www.nextmsc.com/peru-in-vitro-diagnostics-market/request-sample

The in vitro diagnostics market is rapidly expanding in this region due to the significant increase in the healthcare sector.

The chronic disease such as cancer often require ongoing monitoring and management, which further increases the demand for IVD tests.

The promising players operating in the Peru in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.